Entheon Biomedical (XCNQ:ENBI) Scaled Net Operating Assets : -0.07 (As of Nov. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Entheon Biomedical's operating assets for the quarter that ended in Nov. 2023 was C$0.06 Mil. Entheon Biomedical's operating liabilities for the quarter that ended in Nov. 2023 was C$0.09 Mil. Entheon Biomedical's Total Assets for the quarter that ended in Aug. 2023 was C$0.43 Mil. Therefore, Entheon Biomedical's scaled net operating assets (SNOA) for the quarter that ended in Nov. 2023 was -0.07.

Entheon Biomedical Scaled Net Operating Assets Historical Data

The historical data trend for Entheon Biomedical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Scaled Net Operating Assets Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Scaled Net Operating Assets

Get a 7-Day Free Trial

1.04

0.31

4.07

-0.01

-0.04

Entheon Biomedical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.01	0.04	-	0.01	-0.07

Competitive Comparison of Entheon Biomedical's Scaled Net Operating Assets

For the Biotechnology subindustry, Entheon Biomedical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Scaled Net Operating Assets falls into.

Entheon Biomedical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Entheon Biomedical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Nov. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Nov. 2023 )
=	(Operating Assets (A: Nov. 2023 )	-	Operating Liabilities (A: Nov. 2023 ))	/	Total Assets (A: Nov. 2022 )
=	(0.056	-	0.085)	/	0.769
=	-0.04

where

	Operating Assets		(A: Nov. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.401	-	0.345
=	0.056

	Operating Liabilities		(A: Nov. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.085	-	0	-	0
=	0.085

Entheon Biomedical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Nov. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Nov. 2023 )
=	(Operating Assets (Q: Nov. 2023 )	-	Operating Liabilities (Q: Nov. 2023 ))	/	Total Assets (Q: Aug. 2023 )
=	(0.056	-	0.085)	/	0.431
=	-0.07

where

	Operating Assets		(Q: Nov. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.401	-	0.345
=	0.056

	Operating Liabilities		(Q: Nov. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.085	-	0	-	0
=	0.085

Entheon Biomedical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines